Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

113 Results

Funding for Systemic Treatment Clinical Trials

Guidelines and Advice

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Status: Archived
ID: 12-6

May 2012

Guidelines and Advice

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Status: Archived
ID: 2-10

Sep 2011

Guidelines and Advice

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Status: Current
Version: 1

Apr 2023

Guidelines and Advice

First-line treatment of advanced-stage Hodgkin lymphoma

Status: Current
ID: ES 6-25

Oct 2024

Guidelines and Advice

Use of Continuous Infusion Pumps During Radiation Treatment: Recommendation Report (March 2012)

Status: Current
ID: GL-C50-29

Mar 2012

Guidelines and Advice

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Status: Archived
ID: 2-16

Sep 2011

Guidelines and Advice

Follow-up Care for Survivors of Lymphoma who have Received Curative-Intent Treatment

Status: Current
ID: 26-5

Apr 2016

Guidelines and Advice

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Status: In-Review
ID: 7-9
Version: 2

Apr 2014

Focal Tumour Ablation Therapy

Funding Process for High-Cost Cancer Drugs

Fiches d’information destinées aux patients sur les régimes médicamenteux

Pages